Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting.

<h4>Background</h4>Non-alcoholic fatty liver disease (NAFLD) is highly prevalent worldwide. Identifying high-risk patients is critical to best utilize limited health care resources. We established a community-based care pathway using 2D ultrasound shear wave elastography (SWE) to identif...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Stephen E Congly, Abdel Aziz Shaheen, Mark G Swain
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0251741&type=printable

Similar Items

Liver Transplantation for Alcoholic Liver Disease: A Devilish Dilemma
by: Stephen E Congly, et al.
Published: (2013-01-01)

Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
by: Jee-Fu Huang, et al.
Published: (2020-01-01)

Screening strategy for non-alcoholic fatty liver disease
by: Saisai Zhang, et al.
Published: (2023-02-01)

Estimating the cost of illness of non‐alcoholic fatty liver disease in Bangladesh
by: Shahinul Alam, et al.
Published: (2023-09-01)

Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting
by: Paula Luque-Linero, et al.
Published: (2024-05-01)

Projected Healthcare System Cost Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in Canada
by: K. Ally Memedovich, et al.
Published: (2024-01-01)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
by: Yajie Fu, et al.
Published: (2022-11-01)

Evaluating the coding accuracy of type 2 diabetes mellitus among patients with non-alcoholic fatty liver disease
by: Seungwon Lee, et al.
Published: (2024-02-01)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
by: Mehdi Foroughi, et al.
Published: (2016-01-01)

The accuracy of fatty liver index for the screening of overweight and obese children for non-alcoholic fatty liver disease in resource limited settings
by: Mawanane Hewa Aruna Devapriya de Silva, et al.
Published: (2022-08-01)

Non alcoholic fatty liver disease
by: Nahum Méndez-Sánchez
Published: (2009-01-01)

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease
by: Michal Pochopien, et al.
Published: (2024-04-01)

Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
by: Marium Ahmed, et al.
Published: (2024-04-01)

Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases
by: Akiko Eguchi, et al.
Published: (2018-03-01)

Principles of risk stratification in nonalcoholic fatty liver disease. A narrative review emphasizing non-invasive strategies
by: Amedeo Lonardo
Published: (2023-08-01)

Cost-effectiveness of Traditional Persian Medicine-Based Diet on Non-Alcoholic Fatty Liver Disease
by: Marita Mohamadshahi, et al.
Published: (2024-02-01)

Curcumin and non-alcoholic fatty liver disease
by: Nasrin Sharifi, et al.
Published: (2024-06-01)

NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
by: L.V. Chistova, et al.
Published: (2010-11-01)

NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
by: L.V. Chistova, et al.
Published: (2010-11-01)

Non-Alcoholic Fatty Liver Disease in Children
by: Jernej Brecelj, et al.
Published: (2021-07-01)

Non-alcoholic fatty liver disease – 2019
by: Editor in-chief
Published: (2019-12-01)

Phospholipids in non-alcoholic fatty liver disease
by: V. V. Skvortsov, et al.
Published: (2022-04-01)

Cerebral hemodynamics in the non-alcoholic fatty liver
by: David Vidal-González, et al.
Published: (2020-11-01)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Daryl Ramai, et al.
Published: (2021-12-01)

The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease
by: Moon Young Kim
Published: (2017-06-01)

A Comparative Study of Inflammatory Markers in Patients with Alcoholic-Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
by: Laishram Sureiya Devi, et al.
Published: (2023-07-01)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)

The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
by: Hyunwoo Oh, et al.
Published: (2023-02-01)

The Interplay of Iron and Lipid Homeostasis in Non-Alcoholic Fatty Liver Disease
by: Clinton J. Kidman, et al.
Published: (2025-03-01)

Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies
by: Han Zhang, et al.
Published: (2021-11-01)

Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01)

New aspects of non-alcoholic fatty liver disease
by: V. V. Tsukanov, et al.
Published: (2015-09-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Genetic Aspects of Non-Alcoholic Fatty Liver Disease
by: Pavel O. Bogomolov, et al.
Published: (2019-01-01)

Gut microbiome in non-alcoholic fatty liver disease
by: Anastasios Mpountouridis, et al.
Published: (2025-01-01)

Arterial stiffness in non-alcoholic fatty liver disease
by: T.V. Chendey, et al.
Published: (2024-06-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

COMORBIDITY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND PSORIASIS
by: Дмитрий Иванович Трухан, et al.
Published: (2025-03-01)

Non-alcoholic fatty liver disease and cognitive impairment
by: Elena V. Onuchina, et al.
Published: (2024-12-01)

Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
by: Saira Rafaqat, et al.
Published: (2024-03-01)